Delivery Order SPE2DB22D1017-SPE2DB23FG3XC

Award Date 9/26/23
Potential Completion Date 9/27/23
Potential Value $18K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,796.76 firm fixed-price delivery order is for the supply of 4,564,943,591 units of Famotidine 20 mg Piggyback 50 ml, a medication used to treat various gastrointestinal conditions. The contract has an ultimate completion date of June 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, SPE2DB20D3101|SPE2DB23FRYN5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,058.88 delivery order is for the supply of 4,562,268,277 tablets of famotidine 20 mg, a medication used for the treatment of conditions such as heartburn and stomach ulcers. The contract has a firm fixed price and an ultimate completion date of September 22, 2023. This award is...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,339.18 firm fixed-price delivery order covers the supply of Famotidine 40 mg/5 ml suspension, a medication used to treat conditions such as heartburn and stomach ulcers. This award is not designated as a set-aside contract. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to deliver 4,563,267,377 tablets of 40 mg famotidine, a generic medication used to treat heartburn and other gastrointestinal conditions. The $22,778.25 firm fixed-price delivery order has an ultimate completion date of January 9, 2024 and is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This is a $3,059.35 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company. The order is for the supply of Famotidine 40mg/5ml, a prescription drug, with a performance period through March 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. The award is placed against Amerisourcebergen Drug Corp's existing indefinite...
This federal contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is a delivery order valued at $1,194.31 for the supply of FAMOTIDINE 20 MG PIGGYBACK 50ML, a pharmaceutical product. The contract is a firm fixed price award with a completion date of February 7, 2024. It is not designated as a set-aside contract. Amerisourcebergen...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $22,440 to Amerisourcebergen Drug Corporation for 90 tablets of famotidine 20 mg. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the specified pharmaceutical product under contract number 4561682510 from its facility in Conshohocken, Pennsylvania. The Defense Logistics Agency supports Department of Defense procurement programs by sourcing medical supplies and pharmaceuticals. No...
The Defense Logistics Agency awarded a delivery order valued at $135,120 to Amerisourcebergen Drug Corporation for 20 milliliter vials of the drug famotidine. Performance will take place in Conshohocken, Pennsylvania under a firm fixed price contract spanning from June 30 to July 3, 2023. As a major supplier of pharmaceuticals and medical supplies, Amerisourcebergen will deliver the requested famotidine to support the Defense Logistics Agency's stockpile of essential medications for military...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Fexofenadine HCL 180 mg tablets. The $4,304.59 Firm Fixed Price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to supply a comprehensive range of...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical) to supply 1,000 tablets of the pharmaceutical product famotidine (Pepcid) for $1,819.26. The delivery order has a period of performance through March 10, 2022 for product delivery to the DLA Troop Support Medical facility located in Conshohocken,...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB23FG3XC
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,311.97, is for the delivery of Famotidine 40 mg tablets to support military healthcare programs.

The award is a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense (DoD) and other federal agencies. The contract does not have a set-aside designation, indicating open competition.

In addition to the DLA contract, Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs. These IDCs demonstrate the company's capacity to meet the diverse and critical pharmaceutical needs of multiple government agencies on a large scale.

Generated 5/12/25, 10:33 AM